This years ARVO meeting in Seattle, Washington will be attended by the Ulster Vision Science Research Group. Tara Moore is an invited speaker at the ‘Genome Engineering: From Discovery to Therapy’ Workshop. Tara and senior lecturer, Andrew Nesbit will deliver presentations on ‘The Use of CRISPR-Cas9 to treat Corneal Disease’, ‘Practical Applications: gene therapy’, ‘Single guide RNA design – two different approaches’ and ‘Analysis of CRISPR-Cas9 Off Targeting’.